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a b s t r a c t
Contaminations with radioactive material may occur in several situations related to
medicine, industry or research. Seriousness of the incident depends mainly on the radioac-
tive element involved; usually there are no major acute health effects, but in the long term
can cause malignancies, leukemia, genetic defects and teratogenic anomalies.
The most common is superﬁcial contamination, but the radioactive material can get into
the body and be retained by the cells of target organs, injuring directly and permanently
sensitive elements of the body. Rapid intervention is very important to remove the radioac-
tive material without spreading it. Work must be performed in a specially prepared area and
personnel involved should wear special protective clothing. For external decontaminationgeneral cleaning techniques are used, usually do not require chemical techniques. For inter-
nal decontamination is necessary to use speciﬁc agents, according to the causative element,
as well physiological interventions to enhance elimination and excretion.
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are considered contaminated. If the reading is less than twice. General aspects
adioactive materials are widely used in medicine, indus-
ry, agriculture and research (Table 1). Unsealed sources of
adionuclides can be easily dispersed and may be taken
mproperly into the body.
Contamination occurs when material that emits ionizing
adiation is deposited on a person (skin, hair, clothing), or
ny place where is it not intended. People who are externally
ontaminated can become internally contaminated if radioac-
ive material gets into their bodies, thus causing a hazard
or internal radiation. The presence of radioactive substances
nside the human body generates risk of internal intakes of
adionuclides with organ’s tissue and cell retention. A person
ontaminated with radioactive materials is being irradiated
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until the radioactive material is removed. Properly completed,
rapid decontamination can limit the spread of contamination
and reduce morbidity and mortality.
A quick survey should provide sufﬁcient evidence of
the presence or absence of gross contamination. Before
decontamination procedures are started gross radioactive
contamination is easily detected via a quick scan of the patient
with appropriate instrumentation. Geiger–Muller counter is
the most common detection device, being generally used for
the survey; an increase in count rate above background indi-
cates the presence of radiation. In general, areas that register
more than twice the previously determined background levelthe background radiation level, it is assumed that the per-
son is not contaminated to a medically signiﬁcant degree.1 A
detailed description of how to carry out a survey can be found
. Published by Elsevier Urban & Partner Sp. z.o.o. All rights reserved.
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Table 1 – Common isotopes used in nuclear medicine.
Isotope Symbol Half-life Photons, Kev (%) Beta Production Use: diagnostic
(D) therapy (T)
Technetium-99m 99m-Tc 6h 140 Generator D
Gallium-67 67-Ga 3.3d 93 (50) 185 (30) 300 (20) Cyclotron D
Indium-111 111-In 2.8d 173 (50), 247 (50) Cyclotron D
Iodine-123 123-I 13h 159 Cyclotron D
Iodine-131 131-I 8d 365 0.807 Reactor D, T
Thallium-201 201-Tl 3d 69–81 (90), 167 (10) Cyclotron D
Fluorine-18 18-F 109.8m 511 Cyclotron D
Nitrogen-13 13-N 10m 511 Cyclotron D
Rubidium-82 82-Rb 1.3m 511 Cyclotron D
Carbon 11 11-C 20.4m 511 Cyclotron D
Lutetium-177 177-Lu 6.7d 208 (11), 113 (6) 0.5 Reactor T
Phosphorus-32 P-32 14.3d 1.7 Reactor T
Rhenium-186 186-Re 3.8d 137 (9) 1.1 Reactor T
Samarium-153 153-Sm 1.9d 103 (29)
Strontium-89 89-Sr 50.5d
Yttrium-90 Y-90 64
in several publications.2,3 The use of uncollimated gamma-
cameras to detecting and quantifying in vivo contamination,
has been show useful for radionuclides emitting gamma-
energies between 0.035 and 1.30MeV.4
Radioactive contamination consists almost always of
radionuclides that emit high-energy alpha, beta, and/or pho-
ton gamma radiation. They have a broad range of penetration
capabilities through tissues. Alpha particles are unable to pen-
etrate to the basal cell layer of the healthy skin, but they can
cause harm if internalized. Beta particles are able to penetrate
several centimeters into tissue. High-energy gamma rays are
nonparticulate formsof radiation that can traverse thehuman
body and can be shielded only by signiﬁcant thicknesses of
lead. Accordingly, if a worker, person, or any place becomes
contaminated from any isotope, the decontamination method
to be used depends upon the location, the isotope type, half
life,mode of radiation and the formof contamination.2,5 Some
publications provide complete individual data sheets for a
wide range of commonly used radionuclides, classiﬁed into
different groups as a function of risk level.6
Usually no immediate life-threatening hazard is associated
with radiation contamination. A patient may have also suf-
fered acute injury; in that case, the ﬁrst priority is to treat
other vital medical conditions to ensure the patient is medi-
cally stable, since contamination does not usually cause acute
medical effects, even in cases of higher exposure.7,8 Signs and
symptoms of radiation injury and/or illness might not appear
for hours to days and sometimes weeks.The challenge of the
decontamination process is to remove the radioactive mate-
rial without spreading it. These materials usually cannot be
neutralized in the strict sense. The best form of eliminat-
ing them is to move from one point to another or transfer
them to discard materials, thus avoiding prolonged contact
with the patient, following basic common sense.2 The ﬁrst
objective is to prevent the spread of radioactive materials
since people who are externally contaminated with radioac-
tive material can contaminate other people or surfaces that
they touch.
To carry out the decontamination work is desirable to
have an area that can be conﬁgured for decontamination, to
prevent the spread of radioactive materials to other areas,0.8 Reactor T
1.5 Reactor T
2.3 Reactor T
equipment, and people. Movement of a contaminated patient
should always be limited to that which is strictly necessary.2
Personnel involved in handling contaminated patients
should be given a personal dosimeter and may wear appropri-
ate protective clothing, like surgical gown, respiratory mask,
double latex gloves and shoe covers. Outer gloves should be
changed frequently to avoid cross-contamination. Eye pro-
tection should also be worn to prevent ocular contamination
from any splashing during the decontamination procedure.
Shielding devices that are normally used for radiology stud-
ies are not recommended because their bulk difﬁcult the
decontamination process and therefore leads to an increased
exposure time, even are not effective shields for the high-
energy emissions.9 Radiation detection devices can readily
locate contaminants in the area to allow decontamination
to take place. In general, the four basic principles of ALARA
(as low as reasonably achievable) recommendations should be
taken into account to reduce exposure; these involveminimiz-
ing the time of exposure, maximizing the distance from the
source, if it is possible, using shielding as appropriate, and the
removal or containment of contamination.10 Protective gear
should be removed after use and placed in a clearly labeled,
sealed plastic container.
General cleaning techniques for external decontamina-
tion usually involve washing with soap and lukewarm water,
although the aid of other techniques may be needed, depend-
ing upon the location, the isotope type and the form of
contamination; thewhole process often demands a signiﬁcant
contribution of resources and can take substantial time.
Children have special medical needs during a radiologic
emergency because the short- and long-term consequences
of a radiation contamination are greater. Some of their tissues
are inherently more radiosensitive to stochastic effect and
they are at greater risk of developing cancer. Also, they tend
to be emotionally less resilient and may incur in long-term
psychological harm. The American Academy of Pediatrics has
issued guidelines and recommendations for children in a radi-
11ologic emergency.
Several readily available reports provide general guidance
to thosewhomaybe called to respond to radionuclide contam-
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. External decontamination
.1. General management
iagnosis of contamination is achieved mainly by history. His-
orical information, including the location of the incident,
uration of exposure, interval between exposure and clinical
valuation, activity and exact location at the time of expo-
ure, and occupation of the victim should be documented. In
he case of an incident, the patient, or any person who was
nvolved in the incident, may know what isotope was being
sed. The incident history should provide some background
or predicting possible internalization of radionuclides. It may
e necessary to sample during the decontamination process,
hich can be analyzed to determine the radionuclide present.
The determination of external contamination will require
nspectionwith standard detector equippedwith beta-gamma
nd alpha probes. The ﬁrst step would be to do a complete
ody survey to demarcate the areas in the body that are
ontaminated.2 If the decontamination cannot begin imme-
iately, locally affected areas should be outlined with a
ermanent marker and covered with wrapping until decon-
amination begins, to prevent its spread. Any wounds or
brasions should be carefully noted. If anybreaks in skin conti-
uity are noted it should be covered with waterproof adhesive
laster. The contamined wounds and the surrounding area
hould have priority in decontamination.
When carrying out decontamination procedures, person-
el should wear double surgical gloves and an apron; in case
he contamination is heavy it is better to be wearing com-
lete surgical clothing and mask. For major incidents detailed
ecommendations have been published.9,15
If possible, contaminated patients should enter the treat-
ent facility through a separate entrance. If a separate
ntrance is not available, the contaminated patient can be
laced on a clean stretcher outside the emergency department
nd wrapped in a cloth sheet before transport to the desired
rea of the hospital. The decontamination room should be
eparated from the rest of the treatment areas of the emer-
ency department and must be equipped with instruments
or monitoring radiation like Geiger–Muller counters.
Convenient supplies for radiation decontamination
nclude disposable waterproof paper for covering the ﬂoor,
ape to secure the covers, emergency medical equipment,
atient sheets and gowns, table with a drainage system to
ollect contaminated washings, large buckets for collection
f waste water, plastic bags for disposal of swabs, clothing
nd trash, lead containers for possible radioactive foreign
odies, solutions for decontamination (saline, water, soap,
ydrogen peroxide) and soft brushes. In addition the supplies
or health care personnel include scrubs, gowns, masks, foot
overs, hats, waterproof gloves, tape to secure the outer cov-
rings, waterproof aprons, dosimeters and pens for labeling
pecimens.
The process begins by carefully removing all contaminated
lothing, working from head to toe and rolling it outward away
rom the patient’s skin, trapping the contaminant material
nside. If necessary, clothing should be cut off, not tearing,
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airborne transmission. This can reduce contamination by as
much as 80–90%.13
The exposed intact skin should be showered or washed
with regular warm water. Hot water must be avoided because
it enhances the absorption of the radioactive material due to
increased skin blood ﬂow. Also, cold water should be avoided
since it closes skin pores trapping contamination inside. Since
most radiologic material is located on the head and hands,
the patient should be in the “head-back” position during
initial showering to prevent run-off into the eyes, nose, or
mouth. Contamination material around these oriﬁces should
be removed; Some times patient’s face may be protected. Early
hand washing is also important.
Decontamination procedures must start from the periph-
ery of the contaminated area and move towards the center.
Care must be taken to ensure that, in any case, contaminated
washings are allowed to run onto uncontaminated areas. The
procedure should begin with soap and water, if this fails, a
weak detergent may be used. Shampoo or detergent may be
used for washing the hair if it is contaminated.
Ideally, all contamination should be removed; however
there are certain considerations which should be taken into
account for determining the damage of decontamination
required. The radioactive substances usually rest on a thin
ﬁlm of oil that covers the outer layer of the skin. Accord-
ingly, decontamination procedures are based on the removal
of this oily ﬁlm. Care must be taken not to irritate the skin.
If it becomes erythematous or if the skin barrier is lost, some
radionuclides couldbeabsorbeddirectly through the skin.Hair
mayneed to be clipped ifwashing is insufﬁcient for decontam-
ination; it should not be shaved, since shaving may increase
absorption.
Final veriﬁcation of decontamination completeness will be
conducted on the stage. If the contamination persists the pro-
cedure may be repeated. If possible, a member of the trained
team should use a radiation detection device to perform a
head-to-toe survey of all areas of the patient’s body.2,3 Irri-
gation of the suspected areas should be done until acceptable
levels are reached, that is, two times the normal background
levels, or when additional efforts are not signiﬁcantly reduc-
ing contamination. In general, no more than two or three
cycles should be attempted. Signs of excessive decontamina-
tion efforts will be more evident 24h later, and two or three
less intensive decontamination efforts are less traumatic to
the skin than one major effort.
In case of small areas of ﬁxed contamination, it could be
covered with adhesive plaster and left for a day. The residual
contamination will come off when the plaster is removed.
Chemical techniques are rarely needed. The 0.5%
hypochlorite solution used for chemicals will also remove
radiological contaminants. For persistent external contami-
nation abrasive soaps or heavy-metal chelating agents such
as EDTA may be carefully used. Commercially available
decontaminating agents appear to have little to offer over
soap and water for the cleaning the contaminated skin by the
short-lived nuclides. In general, 90 s of gentle washing with
soap and water will remove 95–99% of radionuclide activity
present on intact skin.16,17
All contaminated material, clothing, linen, swabs, etc.
should be placed in large impervious plastic bags, sealed and
d rad150 reports of practical oncology an
labeled appropriately for special waste disposal, or, if the
radioactive contaminant has not yet been identiﬁed, for fur-
ther analysis.
If the patient is to be transferred to a specialist unit, he
should be covered with some light non-absorbent clothes to
minimize spread of contamination.
2.2. Special considerations
Body entrance cavities and open wounds require special
decontamination procedures2,18,19 because radioactive mate-
rial uptake may be faster through oriﬁces and mucous
membranes.
Swabs samples should be taken from the mouth, nose and
eyeswith a cotton-tipped applicator, preferable between gums
and teeth, under the tongue and one from each naris. Moist-
ened swabs are recommended for the eyes and ears. If the
possibility of internal contamination is strongly suspected,
negative counts may mean nothing, depending on the time
since the incident occurred.
Mouth rinsing and tooth brushing are encouraged if
radioactive material has entered the oral cavity, not swallow-
ing the ﬂuids. The nose and auditory canals can be irrigated
with a syringe ﬁlled with saline warmed to body temperature,
taking care to avoid irritation. The eyes should be rinsed by
directing a streamofwater from the inner canthus to the outer
canthus, without causing bleeding.
Contaminated open wounds may provide continuous irra-
diation of surrounding tissues and increase the likelihood of
systemic incorporation. This hazard remains until the con-
taminant is removed by cleansing, surgical debridement, or
radionuclide decay. Intervention require copiously irrigation
of the area and re-inspection, as in intact skin, cover the
wound with waterproof dressing to prevent contamination
from irrigation run-off from other areas, and obtain wound
swabs. Standard or povidone-iodine surgical soapmay be used
if there is a concern for microbial contamination. If any par-
ticulate material foreign bodies are present, they should be
removed with forceps and saved for analysis. If surgery is
needed, continuous monitoring of the wound site and any
material removed should be carried out, while intervention
is being undertaken. After surgery it is mandatory to monitor
all the used instruments, following suitable decontamination
procedures before the instruments can be utilized again.
3. Internal decontamination
Internal contamination occurs when radioactive material is
breathed in, swallowed, enters the body through an open
wound or is absorbed through the skin; then, it crosses the
capillary membrane through passive and active diffusion
mechanisms and can be incorporated into body cells, tissues,
or organs. This can be the case of iodine uptake in the thyroid
or radium, plutonium and americium primarily in the bone.
The rate of distribution to each organ is related to the organ
metabolism and ease of chemical transport.1
Treatment for internal contamination begins when the
patient is medically stable and external decontamination is
complete. Rapid intervention is critical, because some iso-iotherapy 1 6 ( 2 0 1 1 ) 147–152
topes can be incorporated by the end organ within hours
or minutes, and then is very difﬁcult to remove them. In
addition to knowing what radionuclides are involved, it may
be necessary to estimate the approximate level of internal
contamination of the patient in order to know whether a
decorporation treatment is necessary at all. Suggestion of
internal contamination by positive nasal or oral swabs should
be conﬁrmed through bioassay monitoring of feces, urine and
possibly of blood. Agencies such as The Centers for Disease
Control and Prevention have developed protocols to convert
thyroid scanners, gamma cameras, and other radiation detec-
tion equipment, commonly found in hospitals, for use as
whole-body counters in case of an emergency event.20
Speciﬁc management of internal contamination depends
upon the radioactive element involved and its chemical form.
In general, radioactive materials are distributed throughout
the body based upon their physical and chemical properties,
this playing a signiﬁcant role in determining treatment. A
soluble radionuclide will be more readily absorbed; hence,
its potential for passing across membranes into circulation
is high. For example, radioiodine and cesium are rapidly
absorbed; plutonium, radium, and strontium are not. The
effect of insoluble isotopes may be more localized.
The goals of internal decontamination are to reduce
absorption and to enhance elimination and excretion to avoid
or minimize the passage to the systemic circulation system.
Once there has been internal tissue deposition, the effective-
ness of any treatment will be signiﬁcantly reduced. Table 2
shows common decorporating agents used for internal decon-
tamination.
3.1. Reduction of gastrointestinal absorption
Gastric absorption can be reduced by stomach lavage and
emetic agents. These strategies may decrease absorption of
radioisotopes if initiated early after gastric contamination, but
they also create the risk of aspiration of radioisotopes, leading
to respiratory contamination.
Laxatives or purgatives, preferably of fast action, will stim-
ulate intestinal motility, and saline cathartics will increase
water movement into the intestine and induce removal of
contents within 3–6h.
Some enteral binding methods have been shown to effec-
tively bind speciﬁc agents of contamination. Barium sulfate,
commonly used for radiographic contrast studies, forms irre-
versible bonds with strontium and radium. Prussian blue –
ferric III hexacyano-ferrate II – binds to cesium-137 and iso-
topes of thallium and blocks the absorption of rubidium.21
Sodium alginate binds strontium and prevents its absorption.
Aluminum and magnesium salts, administered by mouth or
nasogastric tube at a dose of 100ml, bind to strontium, radium
and phosphorus2,22 (Table 2).
3.2. Block uptake in the target organ
All patients who were potentially exposed to radioactive
iodine should be treated with supersaturated potassium
to block thyroid deposition. Potassium iodide competitively
blocks thyroid uptake of radioactive iodine and technetium. It
should be administered immediately after intake or at least
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Table 2 – Decorporation treatment summary.
Decorporation drug Dosiﬁcation Radionuclide
Ammonium chloride Oral 1–2 g q.i.d., for up to 6 consecutive days Strontium
Ca-DTPA, Zn-DTPA i.v. 1 g in 250ml normal saline or 5% dextrose in water, over 1h Americium, plutonium
Calcium oral Generous doses Radium, strontium, barium
Calcium gluconate i.v. 2.5 g administered in 0.5 l D5W over a 4h period. Daily for 6
consecutive days
Strontium
d-Penicillamine Oral 250mg daily between meals and at bedtime. May increase
to 4 or 5 g daily in divided doses
Cobalt, indium, palladium
Potassium iodide Oral 130mg, as soon as possible, and repeat dose daily until
needed
Iodine
Potassium phosphate Oral 250–500mg four time daily with full glass of water each
time, with meals and at bedtime
Phosphorus
Propylthiouracil Oral 100mg three times daily for 8 days Iodine





































Sodium alginate Oral 10 g powder in a 30 cc v
Sodium bicarbonate i.v. 8.9%, 100 or 200 cc vials
uring the ﬁrst 4–6h. Potassium iodine is specially recom-
ended for children and pregnant women. Adult dose is
00mg/day by mouth for 1–2 weeks; it is contraindicated in
ersons with a known allergy to iodine.
Calcium gluconate or calcium chloride limit the incorpora-
ion of strontium or radioactive calcium into the bone. Dose
f 1 g of calcium chloride or 3 g of calcium gluconate adminis-
ered intravenously are recommended.
Oral or intravenous sodium bicarbonate produces urine
lkalinization and converts uranium into uranium bicarbon-
te which is less nephrotoxic.
.3. Diluting agents
ral ﬂuid administration in large doses produces dilution
nd increase renal excretion of the contaminant. This is par-
icularly indicated if tritium (H-3) is present. Approximately
–10 l/d should be administered for 1 week. Sometimes diuret-
cs can be used to promote urinary excretion.
Oral loading with phosphorus salts can increase the elim-
nation of radioactive phosphorus.
.4. Chelating agents
helating agents such as calcium or zinc diethylenetriamine-
entaacetic acid (DTPA) form compounds with speciﬁc
adioisotopes poorly excreted by the kidneys, like rare earths
nd actinides such as californium, plutonium, and americium,
endering them more easily excreted and enhancing elimina-
ion. The dose for either agents is 1 g in 250ml of normal saline
r 5% dextrose in water, intravenously over 1h. No more than
dose per day should be used, and the dose should not be
ractionated.
d-Penicillamine has been used to treat Wilson’s disease, a
enetic defect leading to copper overload, by chelation and
ccelerated excretion of internally deposited copper. A simi-
ar effect is achieved in the case of contamination caused by
adioactive cobalt, reducing to 1/3, approximately, the total
adiation absorbed dose that would have occurred without
reatment. The recommended dose is 250–500mg by mouth
times per day.23d water and drink Strontium
Uranium
3.5. Wound excision
Wound excision may be considered when the wound is con-
taminated with an isotope that has a very long half-life, such
as plutonium.
Overall, the decision to treat or not to treat for internal con-
tamination is based on risk/beneﬁt considerations of the dose
and the age and condition of the individual patient.19,24 Like-
wise, the decision on when to stop treatment is sometimes a
complex issue, which requires the evaluation of the effective-
ness of treatment by sequential bioassays and consideration
of the risks versus the beneﬁts of continuing the therapy.
Several available reports provide general medical guidance,
including dosage, method of administration and precautions
for the use of medications.2,3,13,24,25
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